Pochesci A - Search Results

1

Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancer.

Passaro A, Alesini D, Pochesci A, Cortesi E. Passaro A, et al. Among authors: pochesci a. Anticancer Agents Med Chem. 2014 Jun;14(5):646-50. doi: 10.2174/187152061405140501101624. Anticancer Agents Med Chem. 2014. PMID: 23140355 Review.

2

Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients.

Passaro A, Prelaj A, Pochesci A, Spitaleri G, Rossi G, Del Signore E, Catania C, de Marinis F. Passaro A, et al. Among authors: pochesci a. Drugs Today (Barc). 2017 Aug;53(8):435-446. doi: 10.1358/dot.2017.53.8.2676119. Drugs Today (Barc). 2017. PMID: 29119148 Review.

3

[Immunotherapy in non-small cell lung cancer: evolution of knowledge and clinical advances].

Pochesci A, Passaro A, Catania C, Noberasco C, Del Signore E, Spitaleri G, De Marinis F. Pochesci A, et al. Recenti Prog Med. 2016 Apr;107(4):186-92. doi: 10.1701/2218.23930. Recenti Prog Med. 2016. PMID: 27093328 Italian.

4

Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment.

Passaro A, Guerini-Rocco E, Pochesci A, Vacirca D, Spitaleri G, Catania CM, Rappa A, Barberis M, de Marinis F. Passaro A, et al. Among authors: pochesci a. Pharmacol Res. 2017 Mar;117:406-415. doi: 10.1016/j.phrs.2017.01.003. Epub 2017 Jan 12. Pharmacol Res. 2017. PMID: 28089942 Review.

5

Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.

Rampinelli C, Spitaleri G, Passaro A, Pochesci A, Ancona E, De Marinis F. Rampinelli C, et al. Among authors: pochesci a. Am J Respir Crit Care Med. 2017 Nov 15;196(10):1349-1350. doi: 10.1164/rccm.201705-0875IM. Am J Respir Crit Care Med. 2017. PMID: 28910131 No abstract available.

6

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice.

Passaro A, Lazzari C, Karachaliou N, Spitaleri G, Pochesci A, Catania C, Rosell R, de Marinis F. Passaro A, et al. Among authors: pochesci a. Onco Targets Ther. 2016 Oct 17;9:6361-6376. doi: 10.2147/OTT.S98347. eCollection 2016. Onco Targets Ther. 2016. PMID: 27799783 Free PMC article. Review.

7

Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?

Passaro A, Pochesci A, Spitaleri G, Catania C, Noberasco C, Del Signore E, de Marinis F. Passaro A, et al. Among authors: pochesci a. J Thorac Dis. 2016 Mar;8(3):E217-20. doi: 10.21037/jtd.2016.02.21. J Thorac Dis. 2016. PMID: 27076973 Free PMC article.

8

Afatinib for the first-line treatment of patients with metastatic EGFR-positive NSCLC: a look at the data.

Passaro A, Pochesci A, Spitaleri G, Catania C, Noberasco C, Del Signore E, de Marinis F. Passaro A, et al. Among authors: pochesci a. Expert Rev Clin Pharmacol. 2016 Oct;9(10):1283-1288. doi: 10.1080/17512433.2016.1233059. Epub 2016 Sep 20. Expert Rev Clin Pharmacol. 2016. PMID: 27626838

9

A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial.

Peters S, Danson S, Hasan B, Dafni U, Reinmuth N, Majem M, Tournoy KG, Mark MT, Pless M, Cobo M, Rodriguez-Abreu D, Falchero L, Moran T, Ortega Granados AL, Monnet I, Mohorcic K, Sureda BM, Betticher D, Demedts I, Macias JA, Cuffe S, Luciani A, Sanchez JG, Curioni-Fontecedro A, Gautschi O, Price G, Coate L, von Moos R, Zielinski C, Provencio M, Menis J, Ruepp B, Pochesci A, Roschitzki-Voser H, Besse B, Rabaglio M, O'Brien MER, Stahel RA. Peters S, et al. Among authors: pochesci a. J Thorac Oncol. 2020 Oct;15(10):1647-1656. doi: 10.1016/j.jtho.2020.06.011. Epub 2020 Jun 18. J Thorac Oncol. 2020. PMID: 32565388 Free article. Clinical Trial.

10

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

Levy A, Hendriks LEL, Berghmans T, Faivre-Finn C, GiajLevra M, GiajLevra N, Hasan B, Pochesci A, Girard N, Greillier L, Lantuéjoul S, Edwards J, O'Brien M, Reck M, Besse B, Novello S, Dingemans AC; EORTC Lung Cancer Group (EORTC LCG). Levy A, et al. Among authors: pochesci a. Eur J Cancer. 2019 Nov;122:109-114. doi: 10.1016/j.ejca.2019.09.012. Epub 2019 Oct 28. Eur J Cancer. 2019. PMID: 31671363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page